Premature ejaculation spray enables men to last 6 times longer

Men with premature ejaculation who applied a spray five minutes before intercourse were able to delay their orgasm six times longer than normal, according to latest research

Three hundred men, average age 35, with clinically diagnosed lifelong premature ejaculation (PE) were recruited from 31 centres in the UK and Europe. The volunteers were separated into two groups.

The first group of 200 men used the PSD502 spray containing 7.5mg of lidocaine and 2.5mg of prilocaine. The second group of 100 men, used a placebo (dummy) spray with no active ingredients.

Over a three-month period, couples timed themselves from vaginal pentration to ejaculation during intercourse. After three months of treatment the researchers reported that:

• 90% of the men in the treatment group were able to delay ejaculation for more than one minute following vaginal penetration, compared with 54% in the placebo group.
• 74% of men in the treatment group managed to last more than two minutes before ejaculation, compared with 22% in the placebo group.
• 62% of men in the treatment group said their orgasms were 'good' or 'very good' after three months, compared with 20% before the study started. The figures for the placebo group were slightly lower at the end (19%) than at the start (21%).
• 66% of men in the treatment group said the medication was 'good' or 'excellent' compared with 15% in the placebo group.
• On average, treatment group were able to last 6.3 times longer after penetration when they used the spray. The placebo group lasted 1.7 times longer.

Men in the treatment group who used the spray reported improvements when it came to perceived control, personal distress, satisfaction with sexual intercourse and interpersonal difficulties. No serious side effects were reported.

Lead researcher Professor W Wallace Dinsmore from the Royal Victoria Hospital, Belfast, commented:

"Premature ejaculation can be a very distressing condition for men and can cause distress, frustration and make them avoid sexual intimacy .... previous research suggests that as many as 40% of men will experience premature ejaculation at some time in their lives."

He added:

"Our study shows that when the PSD502 spray was applied to the man's penis five minutes before intercourse it improved both sexual performance and sexual satisfaction, which are key factors in treating premature ejaculation."

We believe that this shows that PSD502 offers significant advantages over other therapies being developed for the treatment of premature ejaculation."

This article was published on Tue 7 April 2009